Transamerica stopped selling new standalone individual long-term care insurance, its TransCare II and TransCare III policies, on March 31, 2021. It still services the policies it had already sold, and most of them are much older: Flex, LTC 3, 4 and 5, Future Care, Protector, the original TransCare forms, UniProduct and group certificates sold through the National Education Association, many first issued by companies later merged into Transamerica Life. It is still repricing all of them. Recent filings commonly ask for increases of 100% to 200%; regulators usually approve far less, often in annual steps, and some spare older policyholders entirely.
This piece assembles what is publicly verifiable about Transamerica's standalone LTC rate-action history from state insurance-department records, explains why a block closed to new sales behaves the way it does, and separates the discontinued standalone policies from the life-insurance LTC riders Transamerica sells today. For the contrast of a carrier that is still writing new standalone-adjacent business, compare our analysis of Mutual of Omaha's active posture; for a closed top-five block, see our John Hancock file. Transamerica sits between the two.
Carrier status — closed to new standalone sales, still in force
Transamerica discontinued new individual standalone long-term care insurance effective March 31, 2021, ending sales of TransCare II and TransCare III. Acceptance of applications under approved multi-life arrangements (worksite and association cases) continued only through June 30, 2021. Existing standalone policies were explicitly not affected — they remain in force and are serviced normally — but agents who sold the product had their agreements converted to "servicing-only," and coverage upgrades stayed open only where a policy gave a right to increase coverage. The servicing-only change took effect after June 30, 2021.
"Discontinued" is not the same as "gone." Those policies are still on Transamerica's books and still subject to rate filings. Transamerica's long-term care coverage for new buyers now comes only as riders on life insurance: an LTC rider on its individual indexed universal life, and, since November 27, 2023, a rider on a universal life policy sold through employers. That is life insurance with an accelerated benefit, not the standalone coverage these filings concern.
The structural consequence of a closed standalone block is the same one that drives Genworth's multi-decade repricing program: when little or no new standalone premium is arriving, the burden of correcting decades of optimistic 1990s and 2000s pricing assumptions — policyholders living longer, lapsing less, and claiming more than the original models projected — falls on the people who already hold the coverage. A rate-increase filing is that actuarial gap, passed through to the in-force book.
The state filing record
There is no single national "Transamerica rate increase" figure, because increases are filed and approved state by state, policy form by policy form. What you pay depends on your state, your policy form and the increases already applied to it. The actions below come from state insurance department decisions and notices.
| State | Decided | Policies | Requested | Approved |
|---|---|---|---|---|
| Pennsylvania | 2019 | Form ICC10 TLC-3 (UniProduct 2), 319 policyholders | 42.33% | 20% |
| Kentucky | 2021 | Four blocks, 6,249 policyholders | 61% | 40% for lifetime-benefit or inflation-protected policies, 15% for others, with a 10-year rate guarantee; buyout offered |
| Pennsylvania | 2021 | Original TransCare, TransCare Companion, TransCare TQ and TransGenerations forms, 1,480 policyholders | 114% | 20% |
| Pennsylvania | 2021 | Flex, LTC 3/4/5, Future Care, Protector and Transamerica Premier forms, 1,642 policyholders | 114% | 20% |
| Pennsylvania | 2022 | Form ICC10 TLC-3, 259 policyholders | 52.72% | All of it, in two steps: 30%, then 17.48% a year later |
| Virginia | 2023 | Original TransCare, TransCare Companion, TransCare TQ and TransGenerations forms, 1,133 policyholders | 30% | 30%, or 0% for limited-benefit policies without inflation protection (average 22.9%); no buyout |
| Maryland | 2024 | Form ICC10 TLC-3 | 101.1% | 15%, then 7% (23.05% total) |
| Maryland | 2024 | Legacy forms including Flex, LTC 3/4/5, Future Care, Protector III and the original TransCare series | 167% | Two annual 15% steps for issue ages under 75; 0% for issue ages 75 and over |
| Iowa | 2024 | UniProduct | 125.6% | Three annual steps of 17.9% (63.9% total) |
| Maryland | 2025 | Form ICC13 TLC-4 (UniProduct 3a, sold as TransCare III) | 52.1% | 15% |
| Pennsylvania | Pending | Several older forms, 2,738 policyholders (filed June 2026) | 156.1% | Outcome not yet published |
| Pennsylvania | Pending | Form ICC10 TLC-3, 209 policyholders (filed September 2026) | 129.95% | Can take effect by default if the Department takes no action by November 11, 2026 |
Three patterns stand out. First, the request is not the outcome. Transamerica routinely files for increases of 100% or more, and states regularly grant a fraction: 20% on a 114% request in Pennsylvania, 23.05% on 101.1% in Maryland. Second, approvals are often phased into annual steps, so a single approval can raise your premium two or three years running. Pennsylvania's 2022 decision granted the full 52.72%, but as 30% and then 17.48% a year later. Third, some states protect older or smaller policies: Maryland gave 0% to issue ages 75 and over on the legacy forms, Virginia gave 0% to limited-benefit policies without inflation protection, and Kentucky and Iowa traded smaller increases for rate guarantees.
The actionable version of this is on your own paperwork, not in a state average. The policy form number is printed on your policy; the increase that applies to you is the one filed against that form in your state. Form ICC10 TLC-3, for example, appears in Transamerica's filings as its "UniProduct 2" series and was sold in the early 2010s, most likely as TransCare II. Our Transamerica carrier file tracks the company's sales status, and our Rate Tracker places it alongside the other carriers.
What a closed standalone block means for your policy
Strip away the carrier name and the takeaways for an in-force Transamerica policyholder are these:
- Expect further increases, filed state by state. Transamerica's rate-increase letters tell policyholders it expects to file further increases, based on its experience with all policies like theirs. Most of its older blocks have had several increases since 2005. A closed standalone block does not stop filing; the realistic planning assumption is recurring increases, sometimes phased across renewal years like the Pennsylvania action.
- Your options when the letter arrives are standardized. However large the increase, the menu inside a rate-hike letter is the same five-choice structure for every carrier. Read the five options inside a rate-hike letter before you respond to the deadline, not after.
- Contingent nonforfeiture may already be on the table. If a cumulative increase crosses the trigger thresholds in NAIC Model Regulation §28, Transamerica must offer you contingent nonforfeiture — a paid-up benefit equal to the premiums you have already paid. It is the single most overlooked option on these letters.
- "Drop it" is a real option, but rarely the right reflex. Walking away from a policy you have funded for fifteen or twenty years forfeits an enormous sunk benefit. The math is specific to your situation — our framework on whether to drop an LTC policy walks through when surrender, reduction, or nonforfeiture beats simply paying the increase.
- Your letter may include a cash buyout. Since 2021 Transamerica has offered many legacy policyholders a lump sum to cancel their policy as an alternative to the increase, and paid-up policyholders get offers too. Some series, including TransCare Companion, TransCare TQ and TransGenerations, are excluded. How the amount is set, the deadline rules and who should keep the policy: Transamerica's long-term care buyout offer.
- Closed-block does not mean financially weak. A run-off posture on the standalone line is a strategic and accounting state, not a solvency verdict. Transamerica remains a large, established insurer still writing other lines. The thing to manage is the premium trajectory on your policy, not a fear that the policy will vanish.
Not sure which option applies to your letter?
Answer three questions to find your starting point.
What did you receive?
What this is not
This is not a buyer's review. Transamerica no longer sells the standalone policies these filings concern, so there is nothing here to "shop." Its life-insurance LTC riders are a separate decision with its own underwriting, costs, and trade-offs that belong in a hybrid-versus-traditional analysis, not a standalone rate-history piece.
It is also not a carrier ranking. That Transamerica's documented increases land in a different band than John Hancock's closed top-five averages is a description of two different books, not a quality judgment — a policyholder cannot change which carrier and which form issued their contract. The filing record is one input for deciding what to do with the policy you already hold.
Coverage scope
This is the latest carrier-trajectory release in the Long Term Care Desk's Rate Tracker series, joining the Genworth, Mutual of Omaha, and John Hancock files. State-by-state filing detail is compiled in each carrier's carrier file on a rolling basis; the figures here reflect state decisions located as of October 2026 and will be expanded as additional state actions are confirmed.
Primary sources
- Pennsylvania Insurance Department rate decision summaries for Transamerica Life: ICC10 TLC-3, February 19, 2019 (SERFF AEGB-131704842); TOLIC forms and legacy forms, August 28, 2021 (AEGB-132758770, AEGB-132761334); ICC10 TLC-3, August 10, 2022 (AEGB-133092985). 2022 decision, 2019 decision
- Pennsylvania Bulletin notices of pending Transamerica filings: 56 Pa.B. 3588 (June 13, 2026) and 56 Pa.B. 6455 (September 26, 2026). June, September
- Lewis & Ellis, presentation to the Kentucky Legislative Research Commission, September 14, 2021: Kentucky's May 26, 2021 decision. legislature.ky.gov
- Virginia Bureau of Insurance, SERFF filing AEGB-133074343 (TOLIC forms), approved March 29, 2023. scc.virginia.gov
- Maryland Insurance Administration, approved long-term care rates for 2024 and 2025. 2024, 2025
- Iowa Insurance Division, "Iowa Rate Increase History Since 2005 (Long Term Care Policy Forms)." iid.iowa.gov
- Transamerica, "LTC Sales Exit Frequently Asked Questions" (2021): end of standalone sales and multi-life enrollment, servicing-only agents. gbslife.com
- Aegon N.V., Form 20-F for 2025: LTC riders on Transamerica life products. sec.gov
- Insurance Business, "Transamerica revamps long-term care with new workplace rider," November 28, 2023. insurancebusinessmag.com
- Transamerica actuarial memorandum to the Maryland Insurance Administration on form ICC10 TLC-3, naming it the "UniProduct 2 Series" (archived). web.archive.org